Inmune Bio(DE:0Y2)
€1.390.00 (0.00%)
DE:0Y2
Inmune Bio earnings date
€1.39
At close:0.00 (0.00%)
Inmune Bio (0Y2) Q4 2023 Earnings Report
0 Followers
DE:0Y2 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.42
- Consensus EPS
- -EUR 0.39
- Beat/Miss
- Missed by -EUR 0.04
- One Year Ago EPS
- -EUR 0.29
DE:0Y2 Q4 2023 Revenue Results
- Actual Revenue
- EUR 25.31K
- Expected Revenue
- EUR 38.87K
- Beat/Miss
- Missed by -EUR 13.56K
- YoY Revenue Growth
- -71.13%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/28/2024
- Time
- After Close
- Conference Call
- Thursday, March 28, 2024
DE:0Y2 Upcoming Earnings
Inmune Bio's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:0Y2 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:0Y2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.19- | -0.18 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.13-0.15 | -0.22 | 29.17% (+0.06) | |
| Aug 06, 2026 | 2026 (Q2) | -0.19-0.05 | -0.95 | 95.24% (+0.90) | |
| May 07, 2026 | 2026 (Q1) | -0.22-0.18 | -0.39 | 53.49% (+0.21) | |
| Mar 30, 2026 | 2025 (Q4) | -0.24-0.18 | -0.36 | 50.50% (+0.18) | |
| Oct 30, 2025 | 2025 (Q3) | -0.29-0.22 | -0.54 | 60.00% (+0.33) | |
| Aug 07, 2025 | 2025 (Q2) | -0.35-0.95 | -0.45 | -110.00% (-0.50) | |
| May 08, 2025 | 2025 (Q1) | -0.43-0.39 | -0.55 | 29.51% (+0.16) | |
| Mar 27, 2025 | 2024 (Q4) | -0.50-0.36 | -0.42 | 14.89% (+0.06) | |
| Oct 31, 2024 | 2024 (Q3) | -0.46-0.54 | -0.43 | -25.00% (-0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
